Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ustekinumab in active psoriatic arthritis (PSUMMIT-2)
NCT01077362Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Mar 2010
- Primary completion
- Mar 2012
- Modality
- Monoclonal Antibodies
- Countries
- 10
01
Overview
A Phase 3 trial of ustekinumab in psoriatic arthritis (PsA), sponsored by Janssen Pharmaceutical. Started Mar 2010; status: completed.
02
Drugs
ustekinumab
03
Conditions
psoriatic arthritis (PsA)
Beyond the preview
Go deeper on NCT01077362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01077362.